OTX-015

Catalog #
27636-1
$295 *
Size: 5 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

OTX-015 is a potent new BRD-inhibitor with evident anti-proliferative activity in several cell lines representative of mature B-cell tumors.

Synonyms
OTX 015; OTX015
Product Info
Storage and Usage
Citations
Purity

≥98% by HPLC

Formula
C25H22ClN5O2S
MW
492 Da
Solubility
Soluble in DMSO
Biological Activity
OTX-015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM for BRD2, BRD3, and BRD4. IC50 Value: 0.192 uM (DLBCL cell lines). In vitro, OTX-015 demonstrated anti-proliferative activity in DLBCL cell lines (median IC50 0.192 µM). Similar results were obtained on SMZL (median IC50 0.165 µM), and on MM cell lines (median IC50 0.449 µM). MCL cell lines appeared less sensitive to OTX-015 (median IC50 2.01 µM). Among DLBCL cell lines, there was no difference based upon the cell of origin of the cell lines.
CAS Registry #
202590-98-5
Background
Bromodomains have an important role in the targeting of chromatin-modifying enzymes to specific sites, including methyltransferases, HATs and transcription factors and regulate diverse biological processes from cell proliferation and differentiation to energy homeostasis and neurological processes.
References
1. Noel, J.K., et al. Mol. Cancer Ther. 12 , C244 (2013).
2. Braun, T., et al. Blood 122, 4218 (2014).